Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GlobeImmune announces closing of initial public offering and full exercise of underwriter's overallotment option

Tuesday, 8 Jul 2014 05:00pm EDT 

GlobeImmune Inc:Announced initial public offering of 1,725,000 shares of its common stock at a price to the public of $10.00 per share, which includes 225,000 shares of common stock sold pursuant to the full exercise of the underwriter's overallotment option.Gross proceeds to GlobeImmune from the initial public offering were $17,250,000, before deducting underwriting discounts and commissions and other offering expenses.Aegis Capital Corp acted as sole book-running manager for the offering. 

Company Quote

0.25 +3.52%
27 Feb 2015